• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个 TIAM1-TRIM28 复合物介导了原钙黏蛋白的表观遗传沉默,从而促进了肺癌细胞的迁移。

A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.

机构信息

Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.

The Christie National Health Service Foundation Trust, Manchester M20 4BX, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 2023 Oct 3;120(40):e2300489120. doi: 10.1073/pnas.2300489120. Epub 2023 Sep 25.

DOI:10.1073/pnas.2300489120
PMID:37748077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10556593/
Abstract

Lung cancer is the leading cause of cancer deaths. Its high mortality is associated with high metastatic potential. Here, we show that the RAC1-selective guanine nucleotide exchange factor T cell invasion and metastasis-inducing protein 1 (TIAM1) promotes cell migration and invasion in the most common subtype of lung cancer, non-small-cell lung cancer (NSCLC), through an unexpected nuclear function. We show that TIAM1 interacts with TRIM28, a master regulator of gene expression, in the nucleus of NSCLC cells. We reveal that a TIAM1-TRIM28 complex promotes epithelial-to-mesenchymal transition, a phenotypic switch implicated in cell migration and invasion. This occurs through H3K9me3-induced silencing of protocadherins and by decreasing E-cadherin expression, thereby antagonizing cell-cell adhesion. Consistently, TIAM1 or TRIM28 depletion suppresses the migration of NSCLC cells, while migration is restored by the simultaneous depletion of protocadherins. Importantly, high nuclear TIAM1 in clinical specimens is associated with advanced-stage lung adenocarcinoma, decreased patient survival, and inversely correlates with E-cadherin expression.

摘要

肺癌是癌症死亡的主要原因。其高死亡率与高转移潜能有关。在这里,我们通过一个意想不到的核功能表明,RAC1 选择性鸟嘌呤核苷酸交换因子 T 细胞侵袭和转移诱导蛋白 1(TIAM1)通过核功能促进最常见的肺癌亚型非小细胞肺癌(NSCLC)中的细胞迁移和侵袭。我们表明,TIAM1 在 NSCLC 细胞的核内与 TRIM28 相互作用,TRIM28 是基因表达的主要调节剂。我们揭示了 TIAM1-TRIM28 复合物通过 H3K9me3 诱导的原钙粘蛋白沉默和降低 E-钙粘蛋白表达来促进上皮-间充质转化,这与细胞迁移和侵袭有关。一致地,TIAM1 或 TRIM28 的耗竭抑制了 NSCLC 细胞的迁移,而同时耗竭原钙粘蛋白则恢复了迁移。重要的是,临床标本中高核 TIAM1 与晚期肺腺癌、患者生存率降低相关,并且与 E-钙粘蛋白表达呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/c809e9b80cfb/pnas.2300489120fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/1937ab5c19d5/pnas.2300489120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/e1d814c4e8ea/pnas.2300489120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/da7cd975b722/pnas.2300489120fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/d98a09cb340d/pnas.2300489120fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/ca99fa7cbf23/pnas.2300489120fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/c809e9b80cfb/pnas.2300489120fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/1937ab5c19d5/pnas.2300489120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/e1d814c4e8ea/pnas.2300489120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/da7cd975b722/pnas.2300489120fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/d98a09cb340d/pnas.2300489120fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/ca99fa7cbf23/pnas.2300489120fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df3/10556593/c809e9b80cfb/pnas.2300489120fig06.jpg

相似文献

1
A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.一个 TIAM1-TRIM28 复合物介导了原钙黏蛋白的表观遗传沉默,从而促进了肺癌细胞的迁移。
Proc Natl Acad Sci U S A. 2023 Oct 3;120(40):e2300489120. doi: 10.1073/pnas.2300489120. Epub 2023 Sep 25.
2
TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.TIAM1-RAC1 通过拮抗 Nur77 诱导的 BCL2 构象变化促进小细胞肺癌细胞存活。
Cell Rep. 2021 Nov 9;37(6):109979. doi: 10.1016/j.celrep.2021.109979.
3
HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasion.HUWE1使RAC激活剂TIAM1发生泛素化并将其降解,从而促进细胞间黏附的解体、迁移和侵袭。
Cell Rep. 2015 Jan 6;10(1):88-102. doi: 10.1016/j.celrep.2014.12.012. Epub 2014 Dec 24.
4
TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.TIAM1在细胞质中的破坏复合体以及细胞核中均拮抗TAZ/YAP,以抑制肠上皮细胞的侵袭。
Cancer Cell. 2017 May 8;31(5):621-634.e6. doi: 10.1016/j.ccell.2017.03.007. Epub 2017 Apr 13.
5
Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines.在肺癌细胞系中,Trim28通过调控E-钙黏蛋白和N-钙黏蛋白促进上皮-间质转化。
PLoS One. 2014 Jul 1;9(7):e101040. doi: 10.1371/journal.pone.0101040. eCollection 2014.
6
Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer.Rac1、IQGAP1、Tiam1和E-钙黏蛋白在胃癌中的表达联合分析
Mod Pathol. 2008 May;21(5):544-52. doi: 10.1038/modpathol.2008.3. Epub 2008 Feb 1.
7
Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/β-catenin signaling.Tiam1 通过调节 EMT 促进甲状腺癌转移通过 Wnt/β-catenin 信号通路。
Exp Cell Res. 2018 Jan 15;362(2):532-540. doi: 10.1016/j.yexcr.2017.12.019. Epub 2017 Dec 22.
8
Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.组蛋白甲基转移酶 SETDB1 通过与肝癌中的 Tiam1 相互作用促进细胞增殖和迁移。
BMC Cancer. 2018 May 8;18(1):539. doi: 10.1186/s12885-018-4464-9.
9
Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer.环状 RNA circ-RAD23B 通过 miR-593-3p/CCND2 和 miR-653-5p/TIAM1 通路促进非小细胞肺癌细胞的生长和侵袭。
Biochem Biophys Res Commun. 2019 Mar 12;510(3):462-466. doi: 10.1016/j.bbrc.2019.01.131. Epub 2019 Feb 2.
10
Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro.反义Tiam1在体外下调95D细胞的侵袭能力。
Acta Biochim Biophys Sin (Shanghai). 2004 Aug;36(8):537-40. doi: 10.1093/abbs/36.8.537.

引用本文的文献

1
E-Cadherin: A conductor of cellular signaling.E-钙黏蛋白:细胞信号传导的引导者。
Curr Opin Cell Biol. 2025 Aug;95:102559. doi: 10.1016/j.ceb.2025.102559. Epub 2025 Jun 12.
2
VAV2 Drives EGFR-Mediated Rac1 Responses in Prostate Cancer.VAV2在前列腺癌中驱动表皮生长因子受体介导的Rac1反应。
Mol Cancer Res. 2025 Aug 4;23(8):684-698. doi: 10.1158/1541-7786.MCR-24-0957.
3
CircTADA2A stabilizes p53 via interacting with TRIM28 and suppresses the maintenance of FLT3-ITD acute myeloid leukemia.环状TADA2A通过与TRIM28相互作用来稳定p53,并抑制FLT3-ITD急性髓系白血病的维持。

本文引用的文献

1
TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.TIAM1-RAC1 通过拮抗 Nur77 诱导的 BCL2 构象变化促进小细胞肺癌细胞存活。
Cell Rep. 2021 Nov 9;37(6):109979. doi: 10.1016/j.celrep.2021.109979.
2
Acquired Resistance to KRAS Inhibition in Cancer.癌症中对 KRAS 抑制的获得性耐药。
N Engl J Med. 2021 Jun 24;384(25):2382-2393. doi: 10.1056/NEJMoa2105281.
3
Sotorasib for Lung Cancers with p.G12C Mutation.索托拉西布治疗 p.G12C 突变型肺癌。
Leukemia. 2025 Apr 2. doi: 10.1038/s41375-025-02589-4.
4
CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line.CRYβB2改变细胞黏附以促进三阴性乳腺癌细胞系的侵袭。
BMC Res Notes. 2025 Jan 21;18(1):26. doi: 10.1186/s13104-025-07090-w.
5
PCDHGA10 as a potential prognostic biomarker and correlated with immune infiltration in gastric cancer.PCDHGA10作为一种潜在的预后生物标志物,与胃癌中的免疫浸润相关。
Front Immunol. 2024 Dec 2;15:1500478. doi: 10.3389/fimmu.2024.1500478. eCollection 2024.
6
XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.XAF1 通过组装一个由 ZNF313 介导的降解复合物来拮抗 TRIM28 的活性,从而抑制肿瘤恶性。
Mol Biomed. 2024 Nov 13;5(1):58. doi: 10.1186/s43556-024-00224-9.
7
Histone H3K9 Methylation Is Differentially Modified in Odontogenic Cyst and Tumors.组蛋白H3K9甲基化在牙源性囊肿和肿瘤中存在差异修饰。
Eur J Dent. 2025 Jul;19(3):688-696. doi: 10.1055/s-0044-1791681. Epub 2024 Nov 7.
8
CAFs-derived TIAM1 Promotes OSCC Cell Growth and Metastasis by Regulating ZEB2.癌相关成纤维细胞衍生的TIAM1通过调控ZEB2促进口腔鳞状细胞癌细胞生长和转移。
Cell Biochem Biophys. 2025 Mar;83(1):729-740. doi: 10.1007/s12013-024-01505-4. Epub 2024 Sep 10.
9
TRIM28 in cancer and cancer therapy.TRIM28与癌症及癌症治疗
Front Genet. 2024 Jul 19;15:1431564. doi: 10.3389/fgene.2024.1431564. eCollection 2024.
10
Cinobufacini enhances the therapeutic response of 5-Fluorouracil against gastric cancer by targeting cancer stem cells via AKT/GSK-3β/β-catenin signaling axis.华蟾素通过AKT/GSK-3β/β-连环蛋白信号轴靶向癌症干细胞增强5-氟尿嘧啶对胃癌的治疗反应。
Transl Oncol. 2024 Sep;47:102054. doi: 10.1016/j.tranon.2024.102054. Epub 2024 Jul 5.
N Engl J Med. 2021 Jun 24;384(25):2371-2381. doi: 10.1056/NEJMoa2103695. Epub 2021 Jun 4.
4
The RAC1 activator Tiam1 regulates centriole duplication through controlling PLK4 levels.RAC1 激活剂 Tiam1 通过控制 PLK4 水平调节中心体复制。
J Cell Sci. 2021 Apr 1;134(7). doi: 10.1242/jcs.252502. Epub 2021 Apr 13.
5
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific.KRAS 突变的起源和遗传相互作用具有等位基因和组织特异性。
Nat Commun. 2021 Mar 22;12(1):1808. doi: 10.1038/s41467-021-22125-z.
6
Alveolar progenitor cells and the origin of lung cancer.肺泡祖细胞与肺癌的起源。
J Intern Med. 2021 May;289(5):629-635. doi: 10.1111/joim.13201. Epub 2020 Dec 19.
7
Mechanisms and consequences of dysregulation of the Tiam family of Rac activators in disease.Tiam 家族 Rac 激活因子失调在疾病中的机制和后果。
Biochem Soc Trans. 2020 Dec 18;48(6):2703-2719. doi: 10.1042/BST20200481.
8
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer.上皮间质转化是 KRAS G12C 突变型非小细胞肺癌中对 KRAS G12C 抑制剂内在和获得性耐药的原因。
Clin Cancer Res. 2020 Nov 15;26(22):5962-5973. doi: 10.1158/1078-0432.CCR-20-2077. Epub 2020 Sep 8.
9
Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".对《转移性非小细胞肺癌:ESMO诊断、治疗及随访临床实践指南》的勘误
Ann Oncol. 2019 May;30(5):863-870. doi: 10.1093/annonc/mdy474. Epub 2019 Dec 4.
10
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRAS Inhibition.垂直通路抑制克服 KRAS 抑制的适应性反馈抵抗。
Clin Cancer Res. 2020 Apr 1;26(7):1633-1643. doi: 10.1158/1078-0432.CCR-19-3523. Epub 2019 Nov 27.